New UDI Regulations, Global Labeling Requirements Among Discussion Topics at Second Semi-Annual Meeting
Online PR News – 21-January-2015 – Chicago, IL – The 2nd Semi-Annual Medical Device and Diagnostic Labeling Conference will be held April 30-May 1, 2015 in Arlington, Virginia, offering labeling and regulatory affairs executives an exclusive opportunity to discuss the latest compliancy and regulatory requirements enacted by the FDA, as well as both domestic and global practices.
The conference, hosted by Q1 Productions, will offer sessions, panel discussions, and interactive small group workshops led by some of the industry’s leading experts, as well as a wide variety of topics on best practices and challenges. Speakers and panelists, including Dawn Fowler of Endologix, Melissa Finocchio of Biomerieux, and Jackie Elkin of Medtronic, will be on hand for extensive networking opportunities and to offer insight to UDI regulations, GUDID compliance, evolving global labeling requirements, and much more.
This year, conference delegates will have multiple opportunities for small-group discussion to address specific industry challenges and exchanging strategies and insights. An industry-specific breakout session will allow executives to discuss issues within their sector such as labeling development, data, and compliance, as well as provide a platform for exchanging tips and strategies. In addition to open floor workshops and networking opportunities, delegates will also take part in an interactive SPL Workshop, led by Gary Saner of ReedTech, which will allow for a hands-on approach to Structured Product Labeling, how to mitigate and correct errors in formatting and ensuring a streamlined approach.
For more information on the 2nd Semi-Annual Medical Device and Diagnostic Labeling Conference, please visit www.q1productions.com/labeling, or contact email@example.com.
About the Organizer:
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.